ENO2 and peripheral neuropathy: The study's principal findings demonstrate significant NSE elevation in peripheral neuropathy patients (34% increase, mean 9.18±1.43 vs 6.83±1.52 ng/mL, p<0.001), excellent diagnostic performance (AUC=0.863), and exceptional correlations with established clinical assessment tools (DNE score: rs=0.937).